Invention Grant
- Patent Title: 3,6-disubstituted xanthylium salts
-
Application No.: US15373224Application Date: 2016-12-08
-
Publication No.: US10399955B2Publication Date: 2019-09-03
- Inventor: Scott Clunas , John Mervyn David Storey , Janet Elizabeth Rickard , David Horsley , Charles Robert Harrington , Claude Michel Wischik
- Applicant: WisTa Laboratories Ltd.
- Applicant Address: SG Singapore
- Assignee: WISTA LABORATORIES LTD.
- Current Assignee: WISTA LABORATORIES LTD.
- Current Assignee Address: SG Singapore
- Agency: Foley & Lardner LLP
- Main IPC: C07D311/82
- IPC: C07D311/82 ; C07D335/12 ; C07D241/46 ; C07D265/38 ; C07D311/90 ; C07D491/22 ; C07D493/16 ; A61K31/352 ; A61K31/382 ; A61K31/4545 ; A61K31/4745 ; A61K31/498 ; A61K31/5377 ; A61K31/538 ; A61K45/06 ; C07D491/16 ; G01N33/68 ; A61K9/00 ; A61K31/4025 ; A61K49/00 ; C09B11/24 ; C09B11/28 ; C09B17/00 ; C09B19/00 ; C09B21/00 ; C09B57/00 ; C07D311/84 ; C07D335/14 ; C07D335/20
Abstract:
Described are a compound of formula (II) or (III): The compounds are effective in the treatment of disease, including a tauopathy condition or a disease of tau protein aggregation.
Public/Granted literature
- US20170088534A1 3,6-DISUBSTITUTED XANTHYLIUM SALTS Public/Granted day:2017-03-30
Information query
